Nitrooxyacyl Derivatives of Salicylic Acid: Aspirin-Like Molecules that Covalently Inactivate Cyclooxygenase-1

Effects of AF3442 [ N -(9-ethyl-9 H -carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro

(2009) Annalisa Bruno et al.   BIOCHEMICAL PHARMACOLOGY

Cyclooxygenase-2 Polymorphisms, Aspirin Treatment, and Risk for Colorectal Adenoma Recurrence--Data from a Randomized Clinical Trial

(2009) E. L. Barry et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Nitrooxymethyl-Substituted Analogues of Celecoxib: Synthesis and Pharmacological Characterization

(2009) Donatella Boschi et al.   CHEMISTRY & BIODIVERSITY

Mechanistic Insights into Cyclooxygenase Irreversible Inactivation by Aspirin

(2009) Paolo Tosco et al.   ChemMedChem

Aspirin Use and Survival After Diagnosis of Colorectal Cancer

(2009) Andrew T. Chan   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Isosorbide-Based Aspirin Prodrugs: Integration of Nitric Oxide Releasing Groups

(2009) Michael Jones et al.   JOURNAL OF MEDICINAL CHEMISTRY

(Nitrooxyacyloxy)methyl Esters of Aspirin as Novel Nitric Oxide Releasing Aspirins

(2009) Loretta Lazzarato et al.   JOURNAL OF MEDICINAL CHEMISTRY

Aspirin: Promise and Resistance in the New Millennium

(2008) Carlo Patrono et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Searching for New NO-Donor Aspirin-like Molecules: A New Class of Nitrooxy-acyl Derivatives of Salicylic Acid†

(2008) Loretta Lazzarato et al.   JOURNAL OF MEDICINAL CHEMISTRY

Synthesis and cyclooxygenase inhibitory activities of linear 1-(methanesulfonylphenyl or benzenesulfonamido)-2-(pyridyl)acetylene regioisomers

(2007) Morshed Alam Chowdhury et al.   BIOORGANIC & MEDICINAL CHEMISTRY